Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeMY
Item Type Note
Note The following values have no corresponding Zotero field:
auth-address: Department of Gastroenterology and Digestive Oncology, Paris Descartes University, Hopital Europeen Georges Pompidou, Paris, France. Electronic address: jtaieb75@gmail.com. Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Francophone Federation of Digestive Oncology, Cedex Dijon, France; University of Lyon, Lyon, France; Laboratoire de Biometrie et Biologie Evolutive, Villeurbanne, France; Hospices Civils de Lyon, Service de Biostatistique, Lyon, France. 1st Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany. Department of Gastroenterology, Hopital Universitaire Erasme, Brussels, Belgium. Department of Internal Medicine IV, Klinikum Kreuzschwestern Wels, Austria. UCL Cancer Institute, University College London, London, UK. Department of Oncology, Rigshospitalet, Kobenhavn, Denmark. Universite Paris Descartes, Sorbonne Paris Cite, France; Assistance Publique Hopitaux de Paris, Department of Biology, Hopital Europeen Georges Pompidou, Paris, France; UMR-S775, INSERM, Centre Universitaire des Saints Peres, Paris, France. Statistics Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium. Department of Gastroenterology and Digestive Oncology, Paris Descartes University, Hopital Europeen Georges Pompidou, Paris, France. Catalan Institute of Oncology (IDIBELL), Barcelona, Spain. Hepato-Gastroenterology Department Dijon University Hospital and INSERM U 866, France. EA4340 and Pathology Department, Versailles University and Ambroise Pare Hospital APHP, Boulogne, France. Universite Paris Descartes Sorbonne Paris Cite France; UMR-S775, INSERM, Bases Moleculaires de la Reponse aux Xenobiotiques, Paris France; Assistance Publique Hopitaux de Paris, Department of Biology, Hopital Europeen Georges Pompidou, Paris, France.
alt-title: The Lancet. Oncology
number: 8
accession-num: 24928083
Tags _EndnoteXML import
Date Added 2019/05/22 - 09:42:41
Date Modified 2019/05/22 - 09:42:41
Parent item Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés